Working with TipRanks
Follow Us
Stocks
ETFs
Options
Crypto
Research Tools
Calendars
Calculators
Education
About Us
Working with TipRanks
Follow Us
AnaptysBio Inc (GB:0HFQ)
LSE:0HFQ
AnaptysBio (0HFQ) Share Price & Analysis
0 Followers
0HFQ Stock Chart & Stats
Day’s Range$0 - $0
52-Week Range$13.80 - $29.76
Previous Close$13.8
Volume0.00
Average Volume (3M)186.00
Market Cap
$398.63M
Enterprise Value$3.81M
Total Cash (Recent Filing)$413.05M
Total Debt (Recent Filing)$18.23M
Price to Earnings (P/E)N/A
Beta-0.12
Next Earnings
Mar 04, 2024EPS Estimate
-$1.58Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)N/A
Shares Outstanding26,575,178
10 Day Avg. Volume0
30 Day Avg. Volume186
Standard Deviation0.24
R-Squared0.01
Alpha-0.02
Financial Highlights & Ratios
Price to Book (P/B)3.31
Price to Sales (P/S)98.49
Price to Cash Flow (P/CF)-2.70
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/Revenue0.25
Enterprise Value/Gross Profit0.37
Enterprise Value/Ebitda-0.03
Forecast
1Y Price Target
$25.97Price Target Upside88.23% Upside
Rating ConsensusStrong Buy
Number of Analyst Covering4
AnaptysBio News
Press ReleasesAnaptys Named a BioSpace 2024 Best Places to Work Winner
Ownership Overview
0.00% Insiders
0.00% Mutual Funds
76.24% Other Institutional Investors
23.76% Public Companies and
Individual Investors
0HFQ FAQ
What was AnaptysBio Inc’s price range in the past 12 months?
AnaptysBio Inc lowest share price was $13.80 and its highest was $29.75 in the past 12 months.
What is AnaptysBio Inc’s market cap?
Currently, no data Available
When is AnaptysBio Inc’s upcoming earnings report date?
AnaptysBio Inc’s upcoming earnings report date is Mar 04, 2024 which is in 90 days.
How were AnaptysBio Inc’s earnings last quarter?
AnaptysBio Inc released its earnings results on Nov 02, 2023. The company reported -$1.41 earnings per share for the quarter, beating the consensus estimate of -$1.777 by $0.367.
Is AnaptysBio Inc overvalued?
According to Wall Street analysts AnaptysBio Inc’s price is currently Undervalued.
Does AnaptysBio Inc pay dividends?
AnaptysBio Inc does not currently pay dividends.
What is AnaptysBio Inc’s EPS estimate?
AnaptysBio Inc’s EPS estimate is -$1.58.
How many shares outstanding does AnaptysBio Inc have?
Currently, no data Available
What happened to AnaptysBio Inc’s price movement after its last earnings report?
AnaptysBio Inc reported an EPS of -$1.41 in its last earnings report, beating expectations of -$1.777. Following the earnings report the stock price went same 0%.
Which hedge fund is a major shareholder of AnaptysBio Inc?
Among the largest hedge funds holding AnaptysBio Inc’s share is Woodline Partners LP. It holds AnaptysBio Inc’s shares valued at 15M.
---
AnaptysBio Stock Smart Score
Underperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Strong Buy
Average Price Target:
$25.97 (88.23% Upside)
$25.97 (88.23% Upside)
Blogger Sentiment
Bullish
GB:0HFQ Sentiment 100%
Sector Average 71%
Sector Average 71%
Insider Transactions
Sold Shares
Worth $82.0K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Negative
20 days / 200 days
Momentum
-45.01%
12-Months-Change
Fundamentals
Return on Equity
-74.28%
Trailing 12-Months
Asset Growth
-21.21%
Trailing 12-Months
Learn more about TipRanks Smart Score
Company Description
AnaptysBio Inc
AnaptysBio, Inc. is a clinical stage biotechnology company, which engages in developing antibody product candidates focused on unmet medical needs in inflammation. Its pipeline includes ANB020, ANB019, and checkpoint receptor agonist antibodies. The company was founded by Andrew B. Cubitt, William J. Boyle and Nicholas B. Lydon in November 2005 and is headquartered in San Diego, CA.
---
Corvus Pharmaceuticals
―
Voyager Therapeutics
―
Arvinas Holding Company
―
Sangamo Biosciences
―
AnaptysBio
―
---